Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

DexCom, Inc. - Common Stock (NQ: DXCM )

68.48 -2.28 (-3.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
33 34 Next >
Expert Ratings for DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following analyst ratings: 
Via Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
DexCom (DXCM) Q3 2022 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Why DexCom Stock Is Rising After Hours
DexCom Inc (NASDAQ: DXCM) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected  
Via Benzinga
Bull of the Day: DexCom, Inc. (DXCM)
DexCom makes continuous glucose monitoring systems designed for people with diabetes. 
Via Talk Markets
Dexcom Reports Third Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
$1000 Invested In This Stock 10 Years Ago Would Be Worth $31,000 Today
DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 30.49% on an annualized basis producing an average annual return of 40.98%. Currently, DexCom has a market capitalization of... 
Via Benzinga
Dexcom, Adam Schefter Announce Dexcom U, the First NIL Program for College Athletes With Diabetes
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
Don't overlook these top growth stocks trading at a discount. 
Via The Motley Fool
Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy
DexCom's latest products could drive lasting growth. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
2 Top Stocks to Buy in October and Hold Forever
Don't forget these companies when you're investing in the next bear market. 
Via The Motley Fool
This Is What Whales Are Betting On DexCom
Someone with a lot of money to spend has taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the big position showed up on publicly available... 
Via Benzinga
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday. 
Via Benzinga
Cano Health, Aehr Test Systems, Credit Suisse And Other Big Gainers From Friday
U.S. stocks closed lower with the Dow Jones dropping more than 600 points on Friday. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
3 Diabetes Care Stocks That Could Help Set You Up for Life
These companies are three of the leading manufacturers of continuous glucose monitoring systems. 
Via The Motley Fool
Why DexCom Stock Popped on Friday, Even as the Market Crumbled
The medical device maker could benefit from a pending decision by Medicare that could be a game changer. 
Via The Motley Fool
Analyst Ratings for DexCom
Over the past 3 months, 6 analysts have published their opinion on DexCom (NASDAQ:DXCM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
DraftKings, Credit Suisse And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday. 
Via Benzinga
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
DexCom Promotes Jake Leach to Chief Operating Officer
From DexCom, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Looking Into DexCom's Return On Capital Employed
Pulled from Benzinga Pro data, DexCom (NASDAQ:DXCM) showed a loss in earnings since Q1, totaling $50.90 million. Sales, on the other hand, increased by 10.08% to $692.20 million during Q2. 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.